Innovations in Immunology: Drug resistance is a constant threat to progress in HIV, TB and malaria vaccines

September 3, 2019

Despite global efforts at prevention and improving control, the public health impact of these diseases is still huge. Medicines are the mainstay of control efforts, but drug resistance is a constant threat. Effective vaccines are urgently required and would add substantially to the ongoing efforts to curb these diseases.

The first vaccine against malaria to receive a positive opinion from the European Medicines Agency will soon be tested in implementation trials in three African countries: Kenya, Malawi and Ghana.

Read the full article here

More News

We have a winner! 2020 Early Career Research Prize in Vaccinology R&D

May 18, 2020Vaccine Committee (VAC)

2020 Edition: Day of Immunology

April 30, 2020

Menarini Prize for Outstanding Woman Immunologist

April 29, 2020Gender Equality Committee (GEC)

Announcement of a New “Travel for Expertise” Travel Grant Program

April 23, 2020Gender Equality Committee (GEC)

Webinar on-demand: Rino Rappuoli on COVID-19 Vaccines

April 8, 2020

Webinar: COVID-19 Vaccines

April 3, 2020

The British Immunological Society launches the “Celebrate Vaccines” campaign on March 26

March 25, 2020

CALL FOR EXPERTS: IUIS-Frontiers in Immunology Webinar Series on COVID-19

March 13, 2020

Modified tuberculosis vaccine as therapy against bladder cancer

March 5, 2020